• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) SKINVIVE BY JUVEDERM XC 2X1 ML; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) SKINVIVE BY JUVEDERM XC 2X1 ML; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 98307
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Obstruction/Occlusion (2422)
Event Date 03/08/2024
Event Type  Injury  
Manufacturer Narrative
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional (hcp) reported patient was injected with 1 syringe of skinvive¿ by juvéderm per cheek, intradermally while aspirating at each injection site.Immediately post injection, bruise was observed on right cheek.Capillary refill less than 3 seconds.No discoloration other than a blue hematoma approximately 0.5cm in diameter.Capillary refill checked bilaterally after all injections were complete, approximately 45 minutes later, with no sign of vascular event nor pain.A couple hours post injection, patient noticed mottling on right cheek and decreased capillary refill.Blanching and livedo reticularis observed along the right lateral nose, nasolabial fold, and lateral to oral commissure.New hematoma observed on right cheek 4 cm inferior to the orbital rim, in line with lateral canthus.Patient was treated with firm massage, aspirin, heat pack, and 3 vials of hylenex.Blanching appeared to improve with capillary refill of about 3 seconds.The following morning, patient reported increased pain, increased blanching, and increased livedo reticularis and decreased capillary refill.Hcp suspects transverse facial artery was likely affected in the location where the initial hematoma occurred.Hcp assesses patient in person and notes capillary refill is delayed about 4 seconds along the majority of the right cheek.Treatment with heat, massage, 2ml of plain 2% lidocaine, and 9 vials of hylenex.Patient reported soreness and tenderness later that day.The following day, hcp notes slight mottling is observed along the lateral right side of nose and and below the cheekbone but covers less surface area than the day prior.Capillary refill is less than 3 seconds.Ultrasound performed and blow flow appeared the same as non-affected left side.Medtrol pack prescribed to help with inflammation, patient instructed to take ibuprofen for pain and swelling.Symptoms ongoing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SKINVIVE BY JUVEDERM XC 2X1 ML
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
terry ingram
2525 dupont drive
irvine, CA 92612
8479366324
MDR Report Key18961910
MDR Text Key338387221
Report Number9617229-2024-04984
Device Sequence Number1
Product Code LMH
UDI-Device Identifier10840228300066
UDI-Public10840228300066
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number98307
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/08/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-